Last Price
14.22
Today's Change
+0.09 (0.63%)
Day's Change
13.83 - 14.28
Trading Volume
3,978,492
Market Cap
7 Billion
Shares Outstanding
494 Million
Avg Volume
5,137,329
Avg Price (50 Days)
16.32
Avg Price (200 Days)
14.15
PE Ratio
-5.37
EPS
-2.65
Earnings Announcement
05-Aug-2024
Previous Close
14.13
Open
14.08
Day's Range
13.83 - 14.28
Year Range
8.52 - 18.8
Trading Volume
4,041,419
1 Day Change
0.64%
5 Day Change
-0.21%
1 Month Change
-22.93%
3 Month Change
-8.61%
6 Month Change
-7.96%
Ytd Change
-2.87%
1 Year Change
43.64%
3 Year Change
-59.11%
5 Year Change
-58.41%
10 Year Change
-60.50%
Max Change
-60.50%
No result.
Sector: Healthcare - Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Description:
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.